Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sumichika

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Th1 type CD4+ T cells may be a potent effector against poorly immunogenic syngeneic tumorsH Terao, M Harada, S Kurosawa, et al.
Bioscience, Biotechnology, and Biochemistry|December 1, 1994
Streptomyces ATP nucleotide 3'-pyrophosphokinase-gene cloning and sequence analysisT Higuchi, T Mikuniya, K Osoegawa, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Biotherapy (Dordrecht, Netherlands)|January 1, 1994
Th1 type CD4+ T cells may be a potent effector against poorly immunogenic syngeneic tumorsH Terao, M Harada, S Kurosawa, et al.
Bioscience, Biotechnology, and Biochemistry|December 1, 1994
Streptomyces ATP nucleotide 3'-pyrophosphokinase-gene cloning and sequence analysisT Higuchi, T Mikuniya, K Osoegawa, et al.
Pageof 2